Ledger.Open graph →
SEC Form D · filed May 10, 2019

MBX Biosciences, Inc

Offering
$50.0M
Sold
$23.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CARMEL, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Timothy K. Knickerbocker · Carmel, INExec · DirectorRichard K. Dimarchi · Carmel, INExec · DirectorPeter K. Hawryluk · Carmel, INExec · DirectorJoshua Buckley · Brooklyn, NYExec · DirectorAlamin Uddin · Brooklyn, NYExec · DirectorChristoph Janz · Brooklyn, NYExec · DirectorJames F. Connor · Menlo Park, CAExec · DirectorJohn Lykouretzos · NEW YORK, NYExec · DirectorFrederick Brumder · Bend, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗